Key players in the single-cell analysis market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), BD (US), ...

Shares of Danaher Corp. DHR slipped 8.15% to $181.77 Friday, on what proved to be an all-around poor trading session for the ...

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the new Donald Trump administration. Health care stocks can often be a solid defensive play in an uncertain economy.

Partners in Financial Planning has jumped into Danaher with a $433,000 stake, joining a chorus of institutions reshuffling ...

Danaher Corp. closed 29.75% below its 52-week high of $281.70, which the company achieved on August 1st.

Artisan Partners, an investment management company, released its “Artisan Global Opportunities Fund” fourth quarter 2024 ...

RBC Capital analyst Conor McNamara maintained a Buy rating on Danaher (DHR – Research Report) on April 1 and set a price target of $270.00. The ...

Out of all of the options we uncovered, 15 are puts, for a total amount of $1,238,077, and there was 1 call, for a total ...

In February the company had announced its plan to separate the unit, which consists of biosciences and diagnostic solutions, ...

We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to ...

The global US Single-use Assemblies Market is expected to reach US$1658.8 billion by 2029 from US$825.1 billion in 2024, at a ...

Mitsubishi UFJ Asset Management increased its stake in Danaher by 7.5% during the fourth quarter, now holding over a billion ...